Inhaled medicines: past, present, and future

S Anderson, P Atkins, P Bäckman, D Cipolla… - Pharmacological …, 2022 - ASPET
The purpose of this review is to summarize essential pharmacological, pharmaceutical, and
clinical aspects in the field of orally inhaled therapies that may help scientists seeking to …

Long‐acting muscarinic antagonists and small airways in asthma: Which link?

M Cazzola, L Calzetta, MG Matera - Allergy, 2021 - Wiley Online Library
Involvement of small airways, those of< 2 mm in internal diameter, is present in all stages of
asthma and contributes substantially to its pathophysiologic expression. Therefore, small …

[Retracted] Preparation of Curcumin Solid Lipid Nanoparticles Loaded with Flower‐Shaped Lactose for Lung Inhalation and Preliminary Evaluation of Cytotoxicity In …

N Li, X Li, P Cheng, P Yang, P Shi… - Evidence‐Based …, 2021 - Wiley Online Library
The purpose of this study is to design a flower‐shaped lactose loaded curcumin solid lipid
nanoparticles dry powder inhaler and characterize it to improve the solubility and dissolution …

Small Airways: the “silent zone” of 2021 GINA Report?

M Cottini, C Lombardi, G Passalacqua… - Frontiers in …, 2022 - frontiersin.org
Asthma is a chronic disease, affecting approximately 350 million people worldwide.
Inflammation and remodeling in asthma involve the large airways, and it is now widely …

[HTML][HTML] Impact of biologics on lung hyperinflation in patients with severe asthma

M Maniscalco, C Candia, C Calabrese, M D'Amato… - Respiratory …, 2024 - Elsevier
Background In asthma, inflammation affects both the proximal and distal airways and can
cause significant hyperinflation, which is thought to be a major cause of dyspnea. Methods …

Small airway dysfunction and poor asthma control: a dangerous liaison

M Cottini, A Licini, C Lombardi, D Bagnasco… - Clinical and Molecular …, 2021 - Springer
Asthma is a common chronic condition, affecting approximately 339 million people
worldwide. The main goal of the current asthma treatment guidelines is to achieve clinical …

V̇/Q̇ mismatch: a novel target for COPD treatment

JA Neder, M Kirby, G Santyr, M Pourafkari, R Smyth… - Chest, 2022 - Elsevier
In people with COPD, pulmonary gas-exchange efficiency may be impaired because of
abnormal alveolar ventilation (V˙ A), capillary perfusion (Q˙ c), or both. Both have been …

Small airways disease in chronic obstructive pulmonary disease

N Lazarinis, E Fouka, A Linden… - Expert Review of …, 2024 - Taylor & Francis
Introduction Small airway disease (SAD) represents a common and critical feature of
Chronic Obstructive Pulmonary Disease (COPD). Introduced in the'60s, SAD has gradually …

Evaluation of small airway function and its application in patients with chronic obstructive pulmonary disease

Y Li, XY Li, LR Yuan, HL Wang… - Experimental and …, 2021 - spandidos-publications.com
Chronic obstructive pulmonary disease (COPD) is a chronic airway inflammatory disease
characterized by incomplete reversible airflow limitation. The diagnosis of COPD is mainly …

HDAC6 inhibitor ACY-1083 shows lung epithelial protective features in COPD

J Horndahl, R Svärd, P Berntsson, C Wingren, J Li… - PloS one, 2022 - journals.plos.org
Airway epithelial damage is a common feature in respiratory diseases such as COPD and
has been suggested to drive inflammation and progression of disease. These features …